PRIMARY STUDY
Identification of CB₂ receptors in human nigral neurons that degenerate in Parkinson's disease.
Key Findings: These data show for the first time that CB2 receptors are located in tyrosine hydroxylase-containing neurons in the substantia nigra at levels significantly lower in PD patients compared to controls.
Type of Study: Laboratory Study
Study Result: Positive
Study Location(s): Italy, Spain
Year of Pub: 2015
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB2
